Notes on selling, scaling and fixing revenue.
Practical takes on B2B sales, fractional CRO leadership and go-to-market, from 20-plus years carrying the number on five continents.
How Much Pipeline You Really Need to Hit Your Number
Pipeline coverage is quota divided by win rate, adjusted for cycle time. Most teams undercount because the pipeline is stuffed with dead deals.
How to Set Sales Quotas Your Team Can Actually Hit
A quota nobody hits demotivates your team and hides the real problem. Here is how to build quotas bottoms-up from rep capacity and pipeline math.
Sales Comp Plans That Actually Motivate
A good comp plan is simple enough a rep can calculate their own check. Here is how to set base, variable, OTE, and quota by role, and the mistakes to avoid.
$4.6B in Revenue. An $8B Loss. A Possible $2 Trillion Valuation.
Anthropic makes $4.6B, loses $8B+ operating, and could be worth $2 trillion. Three numbers that shouldn't fit together, and in 2026 somehow do.
OpenWeb Raised $390M and Hit a $1.5B Valuation. Now It's Seeking Insolvency Protection.
OpenWeb raised $390M at a $1.5B valuation and now seeks insolvency protection. The lesson for founders: fix the revenue machine while you still have runway.
How to Scale From Founder-Led Sales to a Real Sales Team
Founder-led sales does not scale by hiring. Codify the founder's motion into a playbook, hire to that profile, install management and cadence. Order matters.
Why Your Demos Don't Close
Demos fail when they come before discovery, because you are showing features to a problem you never uncovered. Sell the problem first, then demo to the pain.
How Long Should a B2B Sales Cycle Be (and How to Shorten Yours)
Most B2B sales cycles are long because of stalls and weak qualification, not real complexity. Here are honest benchmarks and the two moves that shorten cycles.
Intel Almost Killed RealSense. Then It Fixed Its Sales and Sold for $600M.
Intel nearly shut RealSense down. Spun out, it went from $8M a quarter to a $600M sale. The technology did not change. The way it sold did.
Outbound vs Inbound for Early-Stage B2B: Where to Start
Inbound compounds but takes many months. Outbound buys control, speed, and market knowledge now. Here is why early-stage B2B almost always needs outbound first.
How to Forecast Revenue When You Have No Sales History
No sales history? A top-down wish is not a forecast. Here is how to build a bottoms-up revenue model from activity and conversion assumptions you can defend.
Your First Sales Hire Keeps Failing. Here Is Why.
If your first sales hire failed and the second is struggling, look at the system before the rep: wrong profile for your stage, no playbook, no management.
How to Build a B2B Sales Process From Scratch
A CRM with random stages is not a sales process. How to build a real B2B sales process from scratch, with buyer-based stages and a forecast you can trust.
How to Hand Off Founder-Led Sales Without Killing the Pipeline
Most founder-led sales handoffs fail because founders dump leads on a rep with no motion. Here is how to transfer the sale without killing your pipeline.
Why Your Startup Can't Sell (And It's Not the Product)
Most founders blame the product when sales stall. The real problem is almost always the motion around it. Here is how to tell, and what to fix first.
When to Hire Your First Salesperson (Founders Wait Too Long, Then Panic)
Revenue milestones do not tell you when to hire your first salesperson. A repeatable motion you can hand off does. Here is what ready actually looks like.
When the Number Falls, Everything You Built on Top of It Comes Due
Arieli borrowed $30M against Elron shares. The stock fell 34% and the partnership is unraveling. The lesson for CEOs: only durable revenue is real collateral.
Stop Paying SDR Retainers for Activity. Pay for Meetings.
Most SDR services bill a flat retainer for activity. I built the opposite: you pay for the qualified B2B meetings we actually book.
A Client Hired Me to Grow Them 30X. Here Is the Honest Answer.
A company hired me to grow them 30X. It can be done, but only if you work backwards from the number and fund the machine that produces it.
BioCatch Sold to Visa for $2.4 Billion. The Lesson Is Not the Technology.
BioCatch went from $7M to $100M ARR before Visa paid $2.4 billion. The lesson for founders is not the tech. It is the repeatable sales machine that scaled it.